Filing Details
- Accession Number:
- 0001209191-14-077759
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-12-23 16:30:26
- Reporting Period:
- 2014-12-19
- Filing Date:
- 2014-12-23
- Accepted Time:
- 2014-12-23 16:30:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1253689 | Glycomimetics Inc | GLYC | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1222543 | A Michael Henos | C/O Glycomimetics, Inc. 401 Professional Drive, Suite 250 Gaithersburg MD 20879 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2014-12-19 | 10,598 | $8.61 | 480,113 | No | 4 | S | Indirect | By fund |
| Common Stock | Disposition | 2014-12-22 | 10,659 | $8.44 | 469,454 | No | 4 | S | Indirect | By fund |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By fund |
| No | 4 | S | Indirect | By fund |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,562 | Direct | |
| Common Stock | 22,668 | Indirect | By spouse |
Footnotes
- The common stock was sold in a series of open market transactions on the transaction date with a volume weighted average sale price of $8.6127. The range of sale prices for the transactions reported was $8.51 to $8.78 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Shares are held of record by Alliance Technology Ventures III, L.P. ("ATV III"). The reporting person is a manager of ATV III Partners, LLC, the general partner of ATV III and shares voting and investment power with respect to the securities held by ATV III, but disclaims beneficial ownership of the securities, except to the extent of his pecuniary interest therein.
- The common stock was sold in a series of open market transactions on the transaction date with a volume weighted average sale price of $8.4354. The range of sale prices for the transactions reported was $8.00 to $8.645 per share. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
